Skip to main content
Erschienen in: Quality of Life Research 12/2015

01.12.2015

Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases

verfasst von: Phantipa Sakthong, Nontapat Sonsa-ardjit, Pattarin Sukarnjanaset, Wipaporn Munpan

Erschienen in: Quality of Life Research | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Due to the problem of high ceiling effects of the EQ-5D-3L, the EQ-5D-5L was developed. However, little was known about the full psychometric properties of the EQ-5D-5L. Thus, this study aimed to evaluate its practicality, reliability, validity, and responsiveness in Thai patients with chronic diseases.

Methods

One thousand one hundred and fifty-six adults taking a medicine at least 3 months were identified from three university hospitals in Bangkok, Thailand, between July 2014 and March 2015. Practicality was evaluated by administration times and ceiling effects. Test–retest reliability was assessed using weighted kappa and intraclass correlation coefficients (ICCs). Validity was tested with correlations between the EQ-5D-5L and WHOQoL-BREF and SF-12v2, and known-groups validity. Responsiveness was measured with standardized effect sizes (SES).

Results

The mean administration time was approximately 2 min, and the ceiling effect of the EQ-5D-5L index was 13.6 %. The weighted kappa values and ICC of the EQ-5D-5L were 0.48–0.61 and 0.82, respectively. Similar dimensions of the EQ-5D-5L had higher correlations with those of WHOQoL-BREF and SF-12v2. As expected, elderly, female, low-educated, unemployed, higher number of comorbidities and medicines, patients’ perception of poor disease control, and having an adverse drug reaction tended to have poorer EQ-5D-5L scores. The SES of EQ-5D-5L index and EQ-VAS were considered small (0.33–0.42) for the improved group. For the worsened group, the SES of the EQ-5D-5L index were considered small (−0.29) but that of the EQ-VAS considered large (−0.82).

Conclusions

The EQ-5D-5L was practical, reliable, valid, and responsive in Thai patients with chronic diseases.
Literatur
1.
Zurück zum Zitat Brooks, R., & EuroQoL Group. (1996). EuroQoL: The current state of play. Health Policy, 37, 53–72.CrossRefPubMed Brooks, R., & EuroQoL Group. (1996). EuroQoL: The current state of play. Health Policy, 37, 53–72.CrossRefPubMed
2.
Zurück zum Zitat Rasanen, P., Roine, E., Sintonen, H., Semberg-Konttinen, V., Ryynanen, O. P., & Roine, R. (2006). Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review. International Journal of Technology Assessment in Health Care, 22, 235–241.CrossRefPubMed Rasanen, P., Roine, E., Sintonen, H., Semberg-Konttinen, V., Ryynanen, O. P., & Roine, R. (2006). Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review. International Journal of Technology Assessment in Health Care, 22, 235–241.CrossRefPubMed
3.
Zurück zum Zitat Sakthong, P. (2008). Measurement of clinical-effect utility. Journal of Medical Association of Thailand, 91, S43–S52. Sakthong, P. (2008). Measurement of clinical-effect utility. Journal of Medical Association of Thailand, 91, S43–S52.
4.
Zurück zum Zitat Brazier, J., Jones, N., & Kind, P. (1993). Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Quality of Life Research, 2, 169–180.CrossRefPubMed Brazier, J., Jones, N., & Kind, P. (1993). Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Quality of Life Research, 2, 169–180.CrossRefPubMed
5.
Zurück zum Zitat Kaarlola, A., Pettila, V., & Kekki, P. (2004). Performance of two measures of general health-related quality of life, the EQ-5D and the RAND-36 among critically ill patients. Intensive Care Medicine, 30, 2245–2252.CrossRefPubMed Kaarlola, A., Pettila, V., & Kekki, P. (2004). Performance of two measures of general health-related quality of life, the EQ-5D and the RAND-36 among critically ill patients. Intensive Care Medicine, 30, 2245–2252.CrossRefPubMed
6.
Zurück zum Zitat Luo, N., Chew, L. H., Fong, K. Y., Koh, D. R., Ng, S. C., Yoon, K. H., et al. (2003). Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Quality of Life Research, 12, 87–92.CrossRefPubMed Luo, N., Chew, L. H., Fong, K. Y., Koh, D. R., Ng, S. C., Yoon, K. H., et al. (2003). Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Quality of Life Research, 12, 87–92.CrossRefPubMed
7.
Zurück zum Zitat Marra, C. A., Woolcott, J. C., Kopec, J. A., Shojania, K., Offer, R., Brazier, J. E., et al. (2005). A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D0 and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science and Medicine, 60, 1571–1582.CrossRefPubMed Marra, C. A., Woolcott, J. C., Kopec, J. A., Shojania, K., Offer, R., Brazier, J. E., et al. (2005). A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D0 and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science and Medicine, 60, 1571–1582.CrossRefPubMed
8.
Zurück zum Zitat Nowels, D., McGloin, J., Westfall, J. M., & Holcomb, S. (2005). Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. Quality of Life Research, 14, 95–105.CrossRefPubMed Nowels, D., McGloin, J., Westfall, J. M., & Holcomb, S. (2005). Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. Quality of Life Research, 14, 95–105.CrossRefPubMed
9.
Zurück zum Zitat Wu, A. W., Jacobson, D. L., Frick, K. D., Clark, R., Revicki, D. A., Freedberg, K. A., et al. (2002). Validity and responsiveness of the EuroQOL as a measure of the health-related quality of life in people enrolled in an AIDS clinical trial. Quality of Life Research, 11, 273–282.CrossRefPubMed Wu, A. W., Jacobson, D. L., Frick, K. D., Clark, R., Revicki, D. A., Freedberg, K. A., et al. (2002). Validity and responsiveness of the EuroQOL as a measure of the health-related quality of life in people enrolled in an AIDS clinical trial. Quality of Life Research, 11, 273–282.CrossRefPubMed
10.
Zurück zum Zitat Sakthong, P., Schommer, J. C., Gross, C. R., Prasithsirikul, W., & Sakulbumrungsil, R. (2009). Health utilities in patients with HIV/AIDS in Thailand. Value in Health, 12, 377–384.CrossRefPubMed Sakthong, P., Schommer, J. C., Gross, C. R., Prasithsirikul, W., & Sakulbumrungsil, R. (2009). Health utilities in patients with HIV/AIDS in Thailand. Value in Health, 12, 377–384.CrossRefPubMed
11.
Zurück zum Zitat Herdman, M., Gudex, C., Lloyd, A., Janssen, M. F., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20, 1727–1736.PubMedCentralCrossRefPubMed Herdman, M., Gudex, C., Lloyd, A., Janssen, M. F., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20, 1727–1736.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Kim, T. H., Jo, M. W., Lee, S. I., Kim, S. H., & Chung, S. M. (2013). Psychometric properties of the EQ-5D-5L in the general population of South Korea. Quality of Life Research, 22, 2245–2253.CrossRefPubMed Kim, T. H., Jo, M. W., Lee, S. I., Kim, S. H., & Chung, S. M. (2013). Psychometric properties of the EQ-5D-5L in the general population of South Korea. Quality of Life Research, 22, 2245–2253.CrossRefPubMed
13.
Zurück zum Zitat Hinz, A., Kohlmann, T., Stobel-Rochter, Y., Zenger, M., & Brahler, E. (2014). The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Quality of Life Research, 23, 443–447.CrossRefPubMed Hinz, A., Kohlmann, T., Stobel-Rochter, Y., Zenger, M., & Brahler, E. (2014). The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Quality of Life Research, 23, 443–447.CrossRefPubMed
14.
Zurück zum Zitat Kim, T. H., Kim, S. H., Lee, S. I., & Jo, M. W. (2012). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21, 1065–1073.CrossRefPubMed Kim, T. H., Kim, S. H., Lee, S. I., & Jo, M. W. (2012). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21, 1065–1073.CrossRefPubMed
15.
Zurück zum Zitat Scalone, L., Coampichini, R., Fagiouli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D-3L with the new version EQ-5D-5L in patients with chronic hepatic diseases. Quality of Life Research, 22, 1707–1716.CrossRefPubMed Scalone, L., Coampichini, R., Fagiouli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D-3L with the new version EQ-5D-5L in patients with chronic hepatic diseases. Quality of Life Research, 22, 1707–1716.CrossRefPubMed
16.
Zurück zum Zitat Golicki, D., Niewada, M., Buczek, J., Karlinska, A., Kobayashi, A., Janssen, M. F., et al. (2014). Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ-VAS in stroke patients. Quality of Life Research,. doi:10.1007/s11136-014-0873-7. Golicki, D., Niewada, M., Buczek, J., Karlinska, A., Kobayashi, A., Janssen, M. F., et al. (2014). Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ-VAS in stroke patients. Quality of Life Research,. doi:10.​1007/​s11136-014-0873-7.
17.
Zurück zum Zitat Golicki, D., Niewada, M., Buczek, J., Karlinska, A., Kobayashi, A., Janssen, M. F., et al. (2015). Validity of EQ-5D-5L in stroke. Quality of Life Research, 24, 845–850.PubMedCentralCrossRefPubMed Golicki, D., Niewada, M., Buczek, J., Karlinska, A., Kobayashi, A., Janssen, M. F., et al. (2015). Validity of EQ-5D-5L in stroke. Quality of Life Research, 24, 845–850.PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Garcia-Gordillo, M. A., Pozo-Cruz, B. D., Adsuar, J. C., Sanchez-Martinez, F. I., & Abelian-Perpinan, J. M. (2014). Validation and comparison of the 15-D and EQ-5D-5L instruments in a Spanish Parkinson’s disease population sample. Quality of Life Research, 23, 1315–1326.CrossRefPubMed Garcia-Gordillo, M. A., Pozo-Cruz, B. D., Adsuar, J. C., Sanchez-Martinez, F. I., & Abelian-Perpinan, J. M. (2014). Validation and comparison of the 15-D and EQ-5D-5L instruments in a Spanish Parkinson’s disease population sample. Quality of Life Research, 23, 1315–1326.CrossRefPubMed
19.
Zurück zum Zitat Tran, B. X., Ohinmaa, A., & Nguyen, L. T. (2012). Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health and Quality of life Outcomes, 10, 132.PubMedCentralCrossRefPubMed Tran, B. X., Ohinmaa, A., & Nguyen, L. T. (2012). Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health and Quality of life Outcomes, 10, 132.PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Agborsangaya, C. B., Lahtinen, M., Cooke, T., & Johnson, J. A. (2014). Comparing the EQ-5D 3L and 5L: Measurement properties and association with chronic conditions and multimorbidity in the general population. Health and Quality of life Outcomes, 12, 74.PubMedCentralCrossRefPubMed Agborsangaya, C. B., Lahtinen, M., Cooke, T., & Johnson, J. A. (2014). Comparing the EQ-5D 3L and 5L: Measurement properties and association with chronic conditions and multimorbidity in the general population. Health and Quality of life Outcomes, 12, 74.PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Pattanaphesaj, J. (2014). Health related quality of life measure (EQ-5D-5L): Measurement property testing and its preference-based score in Thai population. Dissertation, Mahidol University, Bangkok. Pattanaphesaj, J. (2014). Health related quality of life measure (EQ-5D-5L): Measurement property testing and its preference-based score in Thai population. Dissertation, Mahidol University, Bangkok.
22.
Zurück zum Zitat Pattanaphesaj, J., & Thavorncharoensap, M. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in Thai diabetes patients. Health and Quality of life Outcomes, 13, 14.PubMedCentralCrossRefPubMed Pattanaphesaj, J., & Thavorncharoensap, M. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in Thai diabetes patients. Health and Quality of life Outcomes, 13, 14.PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat WHOQOL Group. (1998). The World Health Organization Quality of Life assessment instrument (WHOQOL): Development and general psychometric properties. Social Science and Medicine, 46, 1569–1585.CrossRef WHOQOL Group. (1998). The World Health Organization Quality of Life assessment instrument (WHOQOL): Development and general psychometric properties. Social Science and Medicine, 46, 1569–1585.CrossRef
24.
Zurück zum Zitat WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28, 551–558.CrossRef WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28, 551–558.CrossRef
25.
Zurück zum Zitat Mahatnirunkul, S., Tuntipivatanakul, W., & Pumpisanchai, W. (1998). Comparison of the WHOQOL-100 and the WHOQOL-BREF (26 items). Journal of Mental Health Thai, 5, 4–15. Mahatnirunkul, S., Tuntipivatanakul, W., & Pumpisanchai, W. (1998). Comparison of the WHOQOL-100 and the WHOQOL-BREF (26 items). Journal of Mental Health Thai, 5, 4–15.
26.
Zurück zum Zitat Nunnally, J. C, Jr. (1998). Psychometric theory (2nd ed.). New York: McGraw-Hill. Nunnally, J. C, Jr. (1998). Psychometric theory (2nd ed.). New York: McGraw-Hill.
27.
Zurück zum Zitat Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version two of the SF-36 health survey. Lincoln, RI: Quality Metric, Incorporated. Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version two of the SF-36 health survey. Lincoln, RI: Quality Metric, Incorporated.
28.
Zurück zum Zitat Ware, J. E., Kosinski, M., Turner-Bowker, D., & Gandek, B. (2002). How to score version 2 of the SF-12 health survey. Lincoln, RI: Quality Metric, Incorporated. Ware, J. E., Kosinski, M., Turner-Bowker, D., & Gandek, B. (2002). How to score version 2 of the SF-12 health survey. Lincoln, RI: Quality Metric, Incorporated.
29.
Zurück zum Zitat Rosner, B. (2000). Fundamental of Biostatistics (5th ed.). Pacific Grove, CA: Duxbury Thomson Learning. Rosner, B. (2000). Fundamental of Biostatistics (5th ed.). Pacific Grove, CA: Duxbury Thomson Learning.
30.
Zurück zum Zitat Fleiss, J. L., Levin, B., & Paik, M. C. (2013). Statistical methods for rates and proportions. New Jersey: Wiley. Fleiss, J. L., Levin, B., & Paik, M. C. (2013). Statistical methods for rates and proportions. New Jersey: Wiley.
31.
Zurück zum Zitat Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., et al. (1981). A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics, 30, 239–245.CrossRefPubMed Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., et al. (1981). A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics, 30, 239–245.CrossRefPubMed
32.
Zurück zum Zitat Cohen, P. (1983). Applied multiple regression/correlation analysis for the behavioral sciences (2nd ed.). New Jersey: Lawrence Erlbaum Associates. Cohen, P. (1983). Applied multiple regression/correlation analysis for the behavioral sciences (2nd ed.). New Jersey: Lawrence Erlbaum Associates.
33.
Zurück zum Zitat Sakthong, P., Sakulbumrungsil, R., & Chabunthom, R. (2008). A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes. Health and Quality of Life Outcomes, 6, 71.PubMedCentralCrossRefPubMed Sakthong, P., Sakulbumrungsil, R., & Chabunthom, R. (2008). A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes. Health and Quality of Life Outcomes, 6, 71.PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Sakthong, P., & Kasemsup, V. (2012). Health utility measured with EQ-5D in Thai patients undergoing peritoneal dialysis. Value in Health, 15, S79–S84.CrossRefPubMed Sakthong, P., & Kasemsup, V. (2012). Health utility measured with EQ-5D in Thai patients undergoing peritoneal dialysis. Value in Health, 15, S79–S84.CrossRefPubMed
35.
Zurück zum Zitat Saiguay, W., & Sakthong, P. (2013). The psychometric testing of the Thai version of the health utilities index in patients with ischemic heart disease. Quality of Life Research, 22, 1753–1759.CrossRefPubMed Saiguay, W., & Sakthong, P. (2013). The psychometric testing of the Thai version of the health utilities index in patients with ischemic heart disease. Quality of Life Research, 22, 1753–1759.CrossRefPubMed
36.
Zurück zum Zitat Maindal, H. T., Sokolowski, I., & Vedsted, P. (2009). Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version. BMC Public Health, 9, 209.PubMedCentralCrossRefPubMed Maindal, H. T., Sokolowski, I., & Vedsted, P. (2009). Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version. BMC Public Health, 9, 209.PubMedCentralCrossRefPubMed
Metadaten
Titel
Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases
verfasst von
Phantipa Sakthong
Nontapat Sonsa-ardjit
Pattarin Sukarnjanaset
Wipaporn Munpan
Publikationsdatum
01.12.2015
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 12/2015
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-1038-z

Weitere Artikel der Ausgabe 12/2015

Quality of Life Research 12/2015 Zur Ausgabe